DESTINA Genomics and Mecwins join forces to develop more reliable diagnostic tests Both biotechnology firms have signed a cross-licensing agreement to share technology to develop RNA quantification tests directly from biological samples. Initial tests will focus both on RNA biomarkers for drug-induced hepatotoxicity, nephrotoxicity and cardiotoxicity, and on therapeutic RNAs. Thanks to the combination…
On Wednesday 31 March 2021, DESTINA’s Juan Jose Diaz-Mochon will present the First Single Molecule Counting (SMC™) Application with miRNAs by a PCR Free Method. You can register here to watch the presentation https://lnkd.in/eiMknq9 The high specificity of DESTINA technologies has been implemented within the ultrasensitive SMC™ to yield the platform’s first molecular assays. During his presentation, Juan…
Citation: Talanta, 2020, doi: 10.1016/j.talanta.2020.121265 Abstract Dynamic chemical labelling is a single-base specific method to enable detection and quantification of micro-Ribonucleic Acids in biological fluids without extraction and pre-amplification. In this study, dynamic chemical labelling was combined with the Luminex MAGPIX system to profile levels of microRNA-122 biomarker in serum from patients with Drug-Induced Liver Injury.
Granada 12th October 2020 I was a Spanish academic researcher living in the UK who always wanted to commercialise some of my research through creating a company. I have a happy family background but none of them went onto higher education nor were they high net worth individuals, a ground zero individual as Hugh used…
Edinburgh 23rd September 2020 It is with great sadness that DESTINA Genomics and DESTINA Genomica announce the death of our friend, colleague and CEO Hugh Ilyine. Hugh was found at his desk having only recently been on a call where he had been his usual ebullient and energetic self. Hugh was a founding director and…
DESTINA Genomica SL has joined @Science Exchange, the global platform for outsourced R&D reagents and services. For quotations on the supply of RNA profiling services and custom PNAs synthesis for your research, just contact us via our website. Orders on acceptance can then be made securely through https://www.scienceexchange.com/labs/destina-genomica-sl
DESTINA Genomics has a new redesigned and upgraded website at www.destinagenomics.com Now live, the modernised web design makes access easy to our product and services for PCR free, highly accurate and quantifiable detection of RNA Biomarkers. DESTINA’s unique patented chemistry and how it works is now explained using a 3D Video, with a dynamic new…
On 20th February 2020 at 9:30am GMT, Hugh Ilyine will present, during the New Biomarker Technologies & Data Session, the integration of DESTINA Chemistry within Merck SMCxPro platform for quantifying miRNA molecules directly from body fluids. The title of his talk is Novel Single Molecule Counting (SMC) Of MicroRNA By A PCR Free Method. See…
Citation: Analytical Chemistry, 2020, doi: 10.1021/acs.analchem.9b05449 Abstract Circulating microRNAs are biomarkers reported to be stable and translational across species. MicroRNA-122 (miR-122) is a hepatocyte-specific microRNA biomarker for drug-induced liver injury (DILI). We developed a single molecule, dynamic chemical labeling (DCL) assay to directly detect miR-122 in blood. The DCL assay specifically measured miR-122 directly from 10…
Citation: IEEE Access, 2019, 7, 185677 – 185686 DOI:10.1109/ACCESS.2019.2961230 Abstract A smartphone-based platform for the diagnosis of parasitic infections has been developed, tested and validated. The system is capable of making automatic and accurate analysis of millimetric colorimetric arrays in centrifuge collection tubes, which are well established tools used in clinical analysis. To that end, an Android-based…